Ocular Pharmacology and Toxicology of TRPV1 Antagonist SAF312 (Libvatrep).

Transl Vis Sci Technol · 2023 · PMC10484039 · PMID 37672251

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Groups treated with Acular LS (NSAID) or Maxidex (steroid), reference treatments, showed a trend toward a slightly slower healing rate (no formal statistical analysis was performed), but this minimal difference was not considered clinically or biologically relevant ( Fig. 4 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.